eFFECTOR Therapeutics, Inc. Warrant (EFTRW)

EFTRW was delisted on the 2nd of July, 2024.

• Market cap: $2.34K
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).

Employees: 14